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Abstract
Objective: The purpose of the study was to explore the anti-tumor effect of ultrasound -targeted microbubble
destruction mediated herpes simplex virus thymidine kinase (HSV-TK) suicide gene system on mice hepatoma.
Methods: Forty mice were randomly divided into four groups after the models of subcutaneous transplantation
tumors were estabilished: (1) PBS; (2) HSV-TK (3) HSV-TK+ ultrasound (HSV-TK+US); (4) HSV-TK+ultrasound
+microbubbles (HSV-TK+US+MB). The TK protein expression in liver cancer was detected by western-blot. Applying
TUNEL staining detected tumor cell apoptosis. At last, the inhibition rates and survival time of the animals were
compared among all groups.
Results: The TK protein expression of HSV-TK+MB+US group in tumor-bearing mice tissues were significantly
higher than those in other groups. The tumor inhibitory effect of ultrasound-targeted microbubble destruction
mediated HSV-TK on mice transplantable tumor was significantly higher than those in other groups (p < 0.05), and
can significantly improve the survival time of tumor-bearing mice.
Conclusion: Ultrasound-targeted microbubble destruction can effectively transfect HSV-TK gene into target tissues
and play a significant inhibition effect on tumors, which provides a new strategy for gene therapy in liver cancer.
Introduction
Hepatocellular carcinoma (HCC) is one of the malignant
tumors with high incidence around the world [1,2].
More than one million new cases appeared each year,
particularly in the Asia-Pacific region. This disease has
rapid progress, high recurrence rate and traditional
treatments have limited. With the continuous develop-
ment of molecular biology, gene therapy for liver cancer
has become a research hotspot and direction [3].
However, the safety of viral vector, ineffectiveness of
non-viral gene vectors and other problems limit its
further development [4,5]. Therefore, the search for an
efficient, well targeting and safe gene transfection system
for cancer gene therapy has become a focus of resea-
chers inteset.
Recently a large number of studies have shown that
ultrasound-targeted microbubble destruction is a safe,
effective, non-invasive, and physical gene transfection
technology, which brings a new hope for gene therapy
in liver cancer [6-8]. Ultrasound microbubbles mostly
contain gas [9]. The composition of its shell may include
albumin, lipids, saccharide, non-ionic surfactants, poly-
mers and other materials [10]. At present the size has
been developed to nano-scale and it has the ability to
penetrate the vascular endothelium [11]. Microbubbles
containing gas will be compressed and expansed under
the action of ultrasound with a certain intensity and fre-
quency. When the sound energy reaches certain inten-
sity, the microbubbles are immediately crushed. This
will produce cavitation effect and mechanical effect to
increase the permeability of cell membrane structure in
target region, make the microvessels with the diameter
≤7 μm break down, widen the intercellular gap of vascu-
lar endothelial cells. The exogenous genes can easily
penetrate into the tissues and cells through capillary
vessels to improve the gene transfection rate and
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expression [12,13]. Cavitation effect can also damage
cells, inhibit cell proliferation, and promote tumor cell
apoptosis. When ultrasound-targeted microbubble
generates strong cavitation effects, it can also damage
blood vessel wall, active endogenous or exogenous coa-
gulation, induce large-scale capillary embolism and
block nutrient supply to cancerous cells, leading to dis-
appearance of tumor tissues [14,15].
Suicide gene therapy has been widely used in liver can-
cer treatment and showed a good application prospect.
Especially the herpes simplex virus thymus kinase/ganci-
clovir (HSV-TK/GCV) therapy system is most widely
applied. HSV-TK is a prodrug enzyme gene which can
express and produce TK in the tumor cells, catalyze
nucleoside analogue to form mono- phosphate products,
and further form a triphosphoric acid product under the
effect of phosphokinase in the cell. As a chain terminator,
it will interfere with DNA synthesis during cell division,
leading to tumor cell death [16,17]. A large number of stu-
dies have shown that suicide gene system also has a
“bystander effect”. The effect will kill non-transfected cells
with the transfected cells, which overcomes the shortcom-
ings of the low gene transtection rate and greatly enhances
the anti-tumor effect of suicide gene therapy [18].
In this study, ultrasound microbubbles wrapped HSV-
TK suicide gene had targeted release in mice liver tis-
sues, and improved gene transfection efficiency with the
features of ultrasound and microbubbles. In addition,
the bystander effect of suicide gene fully played the anti-
tumor role. The study provided an efficient, relatively
targeted, non-invasive, and physical gene transfection
method for HSV-TK/GCV system.
Materials and methods
Preparation of lipid microbubbles
Dipalmitoyl phosphatidylcholine (DPPC) (sigma, USA),
distearoyl phosphatidyl ethanolamine (DSPE) (sigma,
USA), diphenyl phosphoryl azide (DPPA) (sigma, USA),
glycerol, PBS were mixed according to a certain propor-
tion and were placed in a 1.5 ml vial, The vials were
incubated at 40°C for 30 minutes. Each vial was filled
with the perfluoropropane gas (C3F8), then the vials
were mechanically shaken for 45 seconds in a dental
amalgamator (YJT, Shanghai Medical Instrument Co.,
Ltd.) and quiescence for 5 min. This solution was
diluted by phosphate-bufferedsaline, sterilized by Co60
and stored at 4°C;. Then the self-made lipid microbub-
bles were made. The average diameter was 1.82 ± 0.45
μm; the average concentration was 1.2 × 1010/ml; the
average potential was -24.7 ± 0.56 mV (n = 4).
Plasmid
The pORF-HSVTK plasmid was carried out PCR ampli-
fication with upstream primer TKF(ACGCGTCGAC
ATGGCCTCGTACCCCGGCCATCAACAC) and down-
stream primer TKR (CGCGGATCCTCAGTTAGCCTC
CCCCATCTCCCGGG) to obtain about 1.2 kb target
HSV-TK fragment. Then directionally connect HSV-TK
target gene fragment and pIRES2-EGFP (Invitrogen,
USA) vect with the help of DNA ligase to obtain recom-
binant plasmid pIRES2-EGFP-TK. The recombinant
plasmid was transformed into DH5a Escherichia coli
competent cells and spread on onkanamycin resistant
LA plate for culture of 12-16 h. When the colonies grew
out, we selected positive clones to extract plasmid,
followed by Sal I and BamH I enzymes cut identification
and sequencing by TaKaRa Company.
Connection of microbubbles with plasmid
According to the method of preparation of gene-loaded lipid
microbubbles from the reference of Zhaoxia Wang [19]. We
mixed the prepared blank lipid microbubbles and poly-L-
lysine (1 mg/ml) (Sigma Corporation, USA), and cultured at
37°C; for 30 min. Subnatant was soaked and deserted and
washed twice by PBS. Naked plasmid (1 mg/ml) was added
and incubated at 37°C; for 30 min, and washed by PBS
twice. The manipulation was repeated three times. then
gene-loaded lipid microbubbles were made. It was measured
the average diameter of the HSV-TK wrapped microbubbles
was between 2 μm to 4 μm and the concentration was 6.9 ×
109/ml. The potential was -3.7 ± 0.56 mv (n = 4) and the
plasmid concentration was 0.1 μg/μl.
Animal model
The study protocol was approved by the Animal
Research Committee of our institution.40 Kunming mice,
cleaning grade, body weight (20 ± 2 g), male, 6 to 8
weeks old, were purchased from the Laboratory Animal
Center of Third Military Medical University. H22 tumor
cells (from Institute of ultrasonography, the second
affiliated Hospital of Chongqing Medical University as a
gift) were cultured in the RPMI 1640 medium (Hyclone,
China) containing 10% betal bovine serum (FBS) at 37°C;
with 5% CO2. We used serum-free RPMI1640 medium
to adjust cell concentration to about 1 × 107/ml, followed
by placenta blue exclusion dye test. The detected cell
activity was >90%. Each mouse was inoculated 0.2 ml cell
suspension subcutaneously in the right flank of Kunming
mice. The tumor diameter was 0.5-1.0 cm after one week
with the tumor rate of 100%. Experimental animals were
randomly divided into four groups (10/per group) :(1)
PBS group; (2) HSV-TK group; (3) HSV-TK+ US group;
(4) HSV-TK+MB+US group.
In vivo transfection by ultrasound combined with HSV-TK
gene microbubbles
The microbubbles containing HSV-TK plasmid were
injected through the tail vein of mice, 200 μl for each
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time. The mice were injected once every 3d and conse-
cutively injected for 3 times. Group A: PBS (200 μl);
Group B: HSV-TK (200 μl, 0.1 μg/μl); group C: US
+HSV-TK (200 μl, 0.1 μg/μl); Group D: US+HSV-TK
+MBs (200 μl, 0.1 μg/μl). Self-made ultrasonic gene
transfection instrument (UTG 1025, Institute of Ultra-
sound Imaging of Chongqing Medical Sciences,
Chongqing, China) was applied on C and D groups for
irradiation after the target gene injection, with the radia-
tion frequency of 1 MHz, sound intensity of 2 W/cm2,
and used pulse irradiation method for 5 min, with the
interval time of 10 s. Each mouse was intraperitoneally
injected 0.2 ml (100 mg·kg-1·d-1) GCV (Roche, Switzer-
land) 48 h after irradiation, which last for 14 days.
Western-blot
Proteins were extracted using protein extraction
reagent,48 hours after transfection and save at -20°C;,
following a protocol provided by the manufacture. TK
protein expression was detected with western-blot. 40
ml/L concentrated gel, 100 ml/L separation gel, pre-
stained protein Marker 3.0 μL, 20 μg/hole sample total
protein. Add sample into 100 mL/L SDS-PAGE followed
by electrophoresis at 60 V. Change voltage to 100 V
after 30 min. Get the gel when bromophenol blue ran to
the bottom after 90 min. Synchronously transfer the
protein to PVDF membrane at 20 V for 50 min. Seal for
4 h with 50 mL/L skim milk TBST at room temperature
after trarsmembrane; add primary antibody (TK1 Poly-
clonal antibody, 1:500) (Abcam, United Kingdom) fol-
lowed by incubation for 2 h at room temperature and
staying overnight at 4°C;. Use TBST to wash membrane
three times with 15 min/time. Add appropriate concen-
tration of secondary antibody combined with HRP
(1:5000) for incubation followed by jiggle at room tem-
perature for 2 h, washing membrane, imaging and expo-
sure. The protein bands were normalized with b-actin,
and all blots were quantified with Software Quantity
One (Bio Rad).
Detection of tumor cell apoptosis with TUNEL staining
After the treatment, the tumor tissues were routinely
paraffin-embedded and made into 5 μm slices. The
sections were dewaxed with xylene followed by gradient
alcohol hydration. Add 20 μg/ml free-DNase protease K
and keep at 37°C; for 15 minutes. Then wash three
times with PBS followed by incubation in 3% hydrogen
peroxide (H2O2) at room temperature for 10 minutes.
Then wash three times with PBS. Add 10 μl b-11-DUTP
and 10 μL TDT to 1 ml Tunel buffer followed by reac-
tion at 37°C; for 1 h and at room temperature for 1 h;
Streptavidin-HRP (1:400) reaction for 30 min; 0.04%
DAB+0.03% H2O2 color development for 10 min; hema-
toxylin contrast dye, differentiation with hydrochloric
acid and ethanol, washing, and sealing with conventional
resin. Then under the optical microscope with 400 times
magnification, five tumor cell areas were randomly
selected. Count the number of total cells and apoptotic
cells to calculate the percentage of TUNEL staining
positive cells, i.e., apoptotic index (AI). AI = (number of
apoptotic cells/the total number of tumor cells) × 100%.
Assessment of therapeutic effect
Measure the tumor size regularly to calculate the inhibi-
tion rate: during treatment use calipers to measure the
maximum diameter a (cm) and the shortest diameter b
(cm) of tumors every 3 d, and apply the formula V =
ab2/2 to calculate the tumor volume with the unit of
cm3. The tumor inhibition rate = (the average size of
tumors in control group- mean tumor volume in treat-
ment group)/mean tumor volume in control group ×
100%. According to the size of the measured tumor
volume, draw the growth curves. Take five mice in each
group for the observations of survival time. The obser-
vation lasts for 80 days and survival curves were drawn.
Statistic analysis
The SPSS17.0 statistic software was used to make a sta-
tistic analysis. The measurement data was expressed as
mean ± SD. The analysis of variance was used to assess
the inhibition rate. LSD-t test was used for pairwise
comparison. Kaplan-Meier method was applied for sur-
vival analysis. A P value less than .05 was considered
indicative of a statistically significant difference.
Results
HSV-TK in vivo transfection effect
48 h after the transfection of ultrasound microbubble
mediated HSV-TK in mice, the TK protein expression
was detected in tissues by western-blot. It was observed
that a single band appeared in each group at 25 kd. The
band in HSV-TK+US+MBs group was the most obvious
(Figure 1).
Figure 1 The expression of TK protein was detected by
Western-blot 48 h after transfection. Each group has a single
band at 25 kDa and the TK protein expression was the highest in
the HSV-TK+ US+MB group (A. PBS group; B. HSV-TK; C. HSV-TK+US;
D. HSV-TK+US+MB).
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Apoptosis
In order to further confirm that microbubble mediated
HSV-TK/GCV treatment system can induce apoptosis
of tumor cells. We applied TUNEL staining to detect
tumor cell apoptosis in each group. When cells under-
went apoptosis, DNA double-strand broke and dUTP
could be marked at the DNA breakage. As can be seen
from each group, the tumor cells in each group
appeared apoptosis in different degrees. The tumor cell
apoptosis in HSV-TK+US+MBs+ GCV group was the
most obvious (Figure 2). Apoptotic index comparison:
group D vs group C, P < 0.05; group D vs group A,
P < 0.001; group A vs group B, P > 0.05 (Table 1).
Treatment effect
As the tumor increases, the mice show obviously ema-
ciated body, appetite loss, dull furs, activity reduction,
body weight loss and so on. However, after treatment the
mice growth in the GCV treatment group is significantly
better than the control group. It can be seen from the
tumor growth curve (Figure 3) that the tumor growth in
group D (HSV-TK+US+MB) slows down significantly.
Compared with the tumor size of control group A (PBS),
the tumor sizes of group D were smaller than group A at
all time points with statistical significance (P < 0.01). The
tumor inhibition rates of group A, B, C and D were: 0%,
3.90% ± 1.80%, 22.70% ± 2.86% and 41.25% ± 3.20%. Take
five mice tumor-bearing in each group as an 80-day con-
tinuous observation of their survival time. It can be seen
from the survival curves (Figure 4) that group D has a sig-
nificant difference (P < 0.05) with other groups in improv-
ing the survival time of tumor-bearing mice.
Discussion
Liver cancer gene therapy requires a non-invasive, effi-
cient, targeting and safe gene transfection technology.
However, ultrasound-targeted microbubble destruction
technology provides a good physical gene transfection
method. The ultrasound can be applied to monitor and
crush the microbubbles in target tissues at the specific
time and space to achieve the accuracy and targeting for
gene therapy. The cavitation and mechanical effects gen-
erated by ultrasound-targeted microbubble destruction
can increase membrane permeability in target areas and
widen the gap of vascular endothelial cells, making it
easier for foreign gene into the target tissue. Most stu-
dies have indicated that under certain ultrasonic irradia-
tion conditions, ultrasound did not destroy the
transfection gene, but enhanced the transfection
efficiency of target genes [20,21].
In this study, microbubble wrapped HSV-TK plasmid
was intravenously injected into mice, followed by ultra-
sound irradiation to tumors in order to smash the
microbubbles for the targeted release of HSV-TK gene.
48 h after transfection, TK protein expression in HSV-
TK+ US+MB+GCV (group D) was significantly higher.
The valid expression of TK protein in the target area is
the premise for tumor treatment HSV-TK/GCV. From
the final treatment effect, the anti-tumor effect of HSV-
TK+US+MB group was the highest amony other groups,
and the survival time of tumor-bearing mice could be
prolonged.
At present, most of the studies in which microbubbles
were chosen as gene carriers applied the method of
Figure 2 Apoptosis expression in four groups of mice liver cancer tissues (original magification × 400). Terminal deoxyuridine nick end-
labeling results showed that cells stained brown in nuclei were apoptotic cells. The tumor cells in two groups appear apoptosis in varying
degree. (a. HSV-TK+US group, b. HSV-TK+US+MB).










AI(%) 12.1 ± 2.0 16.8 ± 2.3 23.5 ± 3.1# 38 ± 3.6*#
Compared with control group, #p < 0.05; compared with other groups, *p <
0.001.
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mixture of microbubble and gene for transfection [22].
Using this approach for gene transfection may affect the
foreign gene transfection efficiency in the target tissues,
making the targeted expression of foreign gene decrease.
In this study, the method of preparation of microbubble
from Wang et al was selected [19]. Through the princi-
ple of electrostatic adsorption, the target genes become
a part of the microbubble shells. This will not only
increase the amount of gene carried by microbubbles,
but also make use of microbubble shells to prevent the
foreign gene from being degraded by DNA enzymes in
the blood. Thereby target gene expression in the target
tissue was increased.
Ultrasound-targeted microbubble destruction technol-
ogy for gene transfection is a kind of transient transfec-
tion. Gene expression time in organizations is relatively
short, rather than other virus-mediated foreign gene
expressions for sustainable long time. The studies from
Aoi A et al have shown that in this method target gene
will obviously decreased 48 h after transfection, which
may be related to the rapid degradation after plasmid
DNA transfection [23]. In this study, the method of
multiple dosing of HSV-TK gene was applied to over-
come the shortcoming that exogenous genes can not
constantly express in transient transfection. The method
of multiple dosing of target gene also shows a great help
for the treatment of tumor. At the same time a lot of
studies have shown that microbubble is a safe, reusable
carrier which will cause immune response rarely which
provides an evidence for multiple dosing of gene in this
study [24].
HSV-TK suicide gene in this study is a pro-drug
enzyme gene. It can transform non-toxic pro-drugs
GCV into cytotoxic drugs by phosphorylation to play an
anti-tumor effect. The TK gene will cause tumor cell
death ultimately with the process of apoptosis [25]. We
used TUNEL staining to assess the tumor apoptosis in
all groups. Compared with the control group, the tumor
cell apoptosis in US+HSV-TK group and HSV-TK+US
+MB group was more obvious. The apoptosis index of
HSV-TK+US+MB group was the highest in the four
groups. This phenomenon illustrates that the microbub-
ble wrapped HSV-TK can significantly increase the TK
gene transfection under the ultrasonic irradiation and
enhance the anti-tumor effects of HSV-TK/GCV system.
On the other hand, the bystander effect of HSV-TK/
GCV system is also strong. Those cells which have not
been transfected can be supplemented by “bystander
effect” to play a good anti-tumor effect [26].
In conclusion, we used an ultrasound contrast agent
as a new type of gene delivery vector, and the anti-
tumor efficacy of HSV-TK was markedly improved.
Ultrasound- targeted microbubble destruction technol-
ogy is expected to become a new gene delivery means
and may provide a novel strategy for targeted cancer
therapy.
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